Back
ESC Premium Access

Influence of pretreatment with aspirin or statins or both on clinical presentation as well as infarct size and inflammation in patients with de novo acute coronary syndromes

Session: Poster Session 3 - Coronary artery disease - Epidemiology and outcomes 2
Topic: Pharmacotherapy
Speaker: Doctor L. Weidmann (Zurich, CH)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Lukas Weidmann

University Heart Center, Zurich (Switzerland)
0 follower

9 more presentations in this session

Role of optimal medical therapy on perioperative outcome in patients with heart failure and coronary artery disease undergoing surgery: insights from the SAS registry

Speaker: Doctor R. Rossini (Cuneo, IT)

Access
Abstract
Slides
Like
Thumbnail

The predictors of neoatherosclerosis after drug-eluting stent implantation evaluated by optical coherence tomography

Speaker: Associate Professor B. Zheng (Beijing, CN)

Access
Abstract
Like
Thumbnail

Gender differences in outcomes of STEMI patients undergoing PCI of the culprit lesion only: experience from the Croatian branch of the ISACS-CT registry

Speaker: Doctor F. Loncaric (Zagreb, HR)

Access
Abstract
Slides
Like
Thumbnail

In-situ skeletonized bilateral internal thoracic artery grafting for left coronary artery revascularization: reflections on a 20-year experience.

Access
Like
Thumbnail

The bleeding and cardiovascular risk according to NSAIDs selectivity in patients receiving antithrombotics and concomitant NSAIDs after myocardial infarction: a nationwide cohort study.

Speaker: Doctor E. Park (Seoul, KR)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 3 - Coronary artery disease - Epidemiology and outcomes 2

Speakers: Doctor L. Weidmann, Doctor R. Rossini, Associate Professor B. Zheng, Doctor F. Loncaric, Doctor E. Park
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources